Advertisement

It’s no surprise that a pervading theme at a conference Monday sponsored jointly by Pfizer Inc. and the Harvard Business School Health Industry Alumni Association was the growing trend toward partnerships between pharmaceutical companies and academia.

Advertisement
Advertisement